A 72-Year-Old with a Positive Blood Culture and a Beta-Lactam Allergy
A 72-year-old man with type 2 diabetes and chronic kidney disease (eGFR 28 mL/min/1.73 m^2) is admitted with fever and right lower extremity cellulitis. Two sets of blood cultures grow gram-positive cocci in clusters from both bottles at 14 hours. He reports a 'severe penicillin allergy' as a child (rash only, no anaphylaxis). He is empirically on vancomycin. The microbiology lab calls to report the Gram stain and asks whether to add a beta-lactam. The patient's MRSA nasal PCR is negative. He has no history of MRSA infection. The team is concerned about nephrotoxicity and wants to narrow therapy.
1. How should the Gram stain and MRSA nasal PCR influence empiric therapy, and what is the significance of the 'penicillin allergy' history?
Read the worked answer
Gram-positive cocci in clusters from both bottles of two sets indicates a true Staphylococcus bacteremia (not a contaminant, given growth in both bottles of both sets and clinical cellulitis). The negative MRSA nasal PCR has a high negative predictive value (~95-98%) for MRSA in most settings, making MSSA more likely and supporting a beta-lactam (e.g., cefazolin or nafcillin) over vancomycin.
The 'severe penicillin allergy' described as a childhood rash without anaphylaxis, angioedema, or SJS is not a true severe allergy - it is a low-risk reaction. Most such histories are not confirmed on testing. Options:
- Penicillin skin testing (major/minor determinants) if available; a negative result allows beta-lactam use.
- If testing is unavailable, a cephalosporin with a low cross-reactivity (cefazolin) is generally safe for rash-only penicillin reactions (<1-2% cross-reactivity).
- Avoid vancomycin as definitive therapy for MSSA because of inferior outcomes and nephrotoxicity, especially with CKD.
Obtain repeat blood cultures at 48-72 hours to document clearance, and consider echocardiography for endocarditis given bacteremia.
2. The isolate is confirmed as Staphylococcus aureus, oxacillin-susceptible (MSSA). The patient's eGFR is 28 mL/min. How would you dose and monitor cefazolin, and what would you do if he developed a rash on cefazolin?
Read the worked answer
Cefazolin dosing in CKD: For eGFR 20-29 mL/min, a typical regimen is 2 g IV every 8-12 hours (some use 2 g q12h for eGFR 10-30). For MSSA bacteremia/cellulitis, target trough levels are not routinely used for cefazolin, but in renal impairment consider cefazolin trough monitoring (goal >20-40 mg/L for bacteremia) or therapeutic drug monitoring if available. Monitor creatinine, CBC, and clinical response; adjust for dialysis if needed.
If a rash develops on cefazolin:
- Assess severity: a morbilliform rash without mucosal involvement or systemic symptoms is a benign drug eruption; stop cefazolin and switch to an alternative.
- Alternatives for MSSA in a penicillin-allergic patient: nafcillin (also a penicillin - avoid if true allergy), ceftaroline (covers MSSA, but not first-line), clindamycin (if susceptible; check D-test for inducible resistance), daptomycin (if vancomycin not appropriate), or linezolid (bacteriostatic for staph; less ideal for bacteremia).
- If the rash is urticarial or anaphylactoid, treat as a true allergy and avoid beta-lactams; consider desensitization if a beta-lactam is essential.
- Document the reaction and refer for allergy evaluation.
3. The patient improves, but on day 10 of cefazolin he develops recurrent fever and a new diastolic murmur. Blood cultures again grow MSSA. What is the most likely explanation and how do you confirm it?
Read the worked answer
Recurrent MSSA bacteremia with a new diastolic murmur on appropriate therapy strongly suggests infective endocarditis, likely with persistent or relapsed infection rather than a new organism. The new diastolic murmur suggests aortic regurgitation from valve involvement.
Confirm with:
- Transthoracic echocardiography (TTE) first; if negative or nondiagnostic, transesophageal echocardiography (TEE) - TEE is more sensitive for vegetations, especially prosthetic valves or small vegetations.
- Repeat blood cultures (at least 2 sets) to document persistent bacteremia and to guide therapy; consider susceptibility testing including MIC to cefazolin and beta-lactamase testing (some MSSA strains have the cefazolin inoculum effect).
- Source control: if a vegetation or abscess is present, surgical consultation for valve replacement/debridement.
- Prolonged IV therapy (4-6 weeks) with an anti-staphylococcal beta-lactam (nafcillin/cefazolin) or vancomycin/daptomycin if beta-lactam allergy; consider combination therapy (e.g., adding gentamicin for native valve) per guidelines.
The most likely explanation is failure to eradicate the source (endocarditis), not antibiotic resistance alone, though the cefazolin inoculum effect should be considered if the isolate is a high-beta-lactamase producer.